Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 3Completed 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Myeloid 1Head & Neck 1

Conditions

Leukemia, Myeloid, Acute 117Myelodysplastic Syndromes 73Leukemia, Myelomonocytic, Chronic 34Leukemia 30Neoplasms 11Carcinoma, Non-Small-Cell Lung 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Myeloproliferative Disorders 8Lymphoma, Non-Hodgkin 8Lymphoma 8Leukemia, Myelomonocytic, Acute 8Congenital Abnormalities 8Recurrence 7Multiple Myeloma 7Lymphoma, Large B-Cell, Diffuse 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Leukemia, Monocytic, Acute 6Leukemia, Erythroblastic, Acute 6Primary Myelofibrosis 5Lung Neoplasms 5Leukemia, Megakaryoblastic, Acute 5Leukemia, Lymphocytic, Chronic, B-Cell 5Hodgkin Disease 5Hematologic Neoplasms 5Anemia, Refractory, with Excess of Blasts 5Prostatic Neoplasms 4Myelodysplastic-Myeloproliferative Diseases 4Melanoma 4Lymphoma, Follicular 4Pancreatic Neoplasms 3

Interventions

Gemcitabine 74Capecitabine 60Paclitaxel 59Fluorouracil 58Oxaliplatin 57Bevacizumab 51Docetaxel 50Leucovorin 48Nivolumab 40Cisplatin 40Irinotecan 39Carboplatin 37Cetuximab 33pembrolizumab 32Radiosurgery 32Trastuzumab 30Radiotherapy 27Everolimus 24Sorafenib 23Pemetrexed 20Doxorubicin 20Albumin-Bound Paclitaxel 20Ipilimumab 19Cyclophosphamide 19Panitumumab 18Zoledronic Acid 17Lapatinib 17Erlotinib Hydrochloride 17Prednisone 16pazopanib 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Neoplasm Metastasis × Azacitidine × Clear all
NCT02269943 2018-12-12

Safety and Efficacy of CC-486 in Previously Treated Patients With Locally Advanced or Metastatic Nasopharyngeal Carcinoma

Celgene

Phase 2 Completed
36 enrolled 24 charts
Head & Neck

Nasopharyngeal Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Neoplasms, Neoplasm Metastasis, Neoplasms, Recurrence, Epstein-Barr Virus Infections

NCT00384956 2016-12-12

A Phase II Study of Intravenous Azacitidine Alone in Patients With Myelodysplastic Syndromes

Washington University School of Medicine

Phase 2 Completed
25 enrolled 13 charts
Myeloid

Myelodysplastic Syndromes, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡